Research Analysts Set Expectations for EYPT FY2025 Earnings
EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT – Free Report) – Cantor Fitzgerald decreased their FY2025 earnings per share (EPS) estimates for shares of EyePoint Pharmaceuticals in a research report issued to clients and investors on Thursday, March 6th. Cantor Fitzgerald analyst J. Kim now anticipates that the company will earn ($2.96) per share for the year, down […]
EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT – Free Report) – Cantor Fitzgerald decreased their FY2025 earnings per share (EPS) estimates for shares of EyePoint Pharmaceuticals in a research report issued to clients and investors on Thursday, March 6th. Cantor Fitzgerald analyst J. Kim now anticipates that the company will earn ($2.96) per share for the year, down […]
